ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARP Annual Meeting 2019

Abstract Number: 1075

The Impact of Race on Birth Outcomes Among Women with Autoimmune Rheumatic Diseases

Lena Sabih1, Jennifer Strouse 1, Nichole Nidey 2, Gretchen Bandoli 3, Rebecca Baer 4, Sky Feuer 5, Laura Jelliffe-Pawlowski 5, Christina Chambers 6, Kelli Ryckman 2 and Namrata Singh 7, 1University of Iowa Hospitals and Clinics, Iowa City, 2UIOWA, Iowa City, 3University of California, San Diego, La Jolla, 4UCSD, La Jolla, 5UCSF, San Francisco, 6UCSD, San Diego, 7University of Iowa, Iowa City

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARP Annual Meeting 2019

Keywords: pregnancy, rheumatoid arthritis (RA) and race/ethnicity, SLE

Session Information

Date: Monday, November 11, 2019

Title: Epidemiology & Public Health Poster II: Spondyloarthritis & Connective Tissue Disease

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Autoimmune rheumatic diseases (ARDs) are associated with adverse pregnancy outcomes (APOs). There are only a small number of studies that have looked at the association of race with APOs, especially in women of Asian race/ethnicity. Black race has been associated with worse APOs in women with ARDs when compared to Non-Hispanic White populations in a small number of studies. The aim of our study is to evaluate the impact of race and rheumatic disease on birth outcomes including preterm birth (PTB), congenital anomalies, low birth weight (LBW), and small for gestational age (SGA) in a large multiethnic cohort of women.

Methods: Birth records linked to hospital discharge data of singleton births in California from 2007 to 2012 were leveraged for a retrospective cohort study including women at least 18 years old diagnosed with ARD. International classification of diseases, ninth revision codes were used to identify women with ARD, as well as PTB, LBW, SGA and congenital anomalies among infants. Race/ethnicity was abstracted from birth record data. The odds of PTB, LBW, SGA and congenital anomalies were estimated in separate logistic regression models and models were adjusted for maternal age, education, insurance and parity.

Results: Among women with an ARD diagnosis (rheumatoid arthritis, systemic lupus erythematosus, antiphospholipid syndrome, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis) who met our eligibility criteria, Black women had a two-fold increased odds of PTB when compared to Non-Hispanic White women (OR 2.09, 95% CI 1.72-2.53). Additionally, Asian (OR 1.63, 95% CI 1.35-1.96) and Hispanic (OR 1.33, 95% CI 1.16-1.52) women were also more likely to give birth preterm. In women with RA, increased OR of PTB was only significant in Black women compared to Non-Hispanic White women. The odds of SGA were significantly increased for Asian (OR 2.33, 95% CI 1.92-2.83), Black (OR 2.24, 95% CI 1.89-2.89) and Hispanic women with any ARD compared with Non-Hispanic White women and remained significant for those with RA and SLE. Among women with any diagnosis of an ARD, race was not significantly associated with premature rupture of membranes except for Black women (OR 1.53, 95% CI 1.04-2.24).

Conclusion: Our findings support previous work that among women with an ARD diagnosis, minority race is a risk factor for adverse pregnancy outcomes including PTB and SGA. Although the etiology of this increased risk is not fully understood socioeconomic and genetic contributions have been proposed in prior work. Our study is the first study with a large group of women with Asian race/ethnicity and found that this group, along with Hispanic and Black women, have an increased risk of adverse pregnancy outcomes when compared with Non-Hispanic White women. Asian, Black, and Hispanic women with ARDs should undergo increased monitoring during pregnancies.


ARD PTB Table 1 060419

Effect of race on pregnancy outcomes in singleton births of women 18 years and older with ARD in California from 2007 to 2012


Disclosure: L. Sabih, None; J. Strouse, None; N. Nidey, None; G. Bandoli, None; R. Baer, None; S. Feuer, None; L. Jelliffe-Pawlowski, None; C. Chambers, AbbVie, 9, Amgen Inc., 9, Apotex, 9, Barr Laboratories, Inc., Bristol-Myers Squibb, 9, Celgene, GlaxoSmithKline, Janssen Pharmaceuticals, 9, Kali Laboratories, Inc., 9, Pfizer, Inc., 9, Hoffman La Roche-Genentech, Sandoz Pharmaceuticals, 9, Genzyme Sanofi-Aventis, Takeda Pharmaceutical Company Limited, 9, Teva Pharmaceutical Industries Ltd., 9, UCB, USA, 9, Gerber Foundation, 9; K. Ryckman, None; N. Singh, None.

To cite this abstract in AMA style:

Sabih L, Strouse J, Nidey N, Bandoli G, Baer R, Feuer S, Jelliffe-Pawlowski L, Chambers C, Ryckman K, Singh N. The Impact of Race on Birth Outcomes Among Women with Autoimmune Rheumatic Diseases [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-impact-of-race-on-birth-outcomes-among-women-with-autoimmune-rheumatic-diseases/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-race-on-birth-outcomes-among-women-with-autoimmune-rheumatic-diseases/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology